Page last updated: 2024-09-03

inositol-3,4,5,6-tetrakisphosphate and epidermal growth factor

inositol-3,4,5,6-tetrakisphosphate has been researched along with epidermal growth factor in 1 studies

Compound Research Comparison

Studies
(inositol-3,4,5,6-tetrakisphosphate)
Trials
(inositol-3,4,5,6-tetrakisphosphate)
Recent Studies (post-2010)
(inositol-3,4,5,6-tetrakisphosphate)
Studies
(epidermal growth factor)
Trials
(epidermal growth factor)
Recent Studies (post-2010) (epidermal growth factor)
680824,1552174,699

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Eckmann, L; Fierer, J; Jiang, T; Kagnoff, MF; Ptasznik, A; Rudolf, MT; Schultz, C; Shears, SB; Traynor-Kaplan, AE; Tsien, R; Wolfson, N1

Other Studies

1 other study(ies) available for inositol-3,4,5,6-tetrakisphosphate and epidermal growth factor

ArticleYear
D-myo-Inositol 1,4,5,6-tetrakisphosphate produced in human intestinal epithelial cells in response to Salmonella invasion inhibits phosphoinositide 3-kinase signaling pathways.
    Proceedings of the National Academy of Sciences of the United States of America, 1997, Dec-23, Volume: 94, Issue:26

    Topics: Epidermal Growth Factor; Humans; Inositol Phosphates; Intestinal Mucosa; Phosphatidylinositol 3-Kinases; Salmonella Infections; Signal Transduction

1997